• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION NEU_INTERSTIM_INS; INTESTINAL STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION NEU_INTERSTIM_INS; INTESTINAL STIMULATOR Back to Search Results
Model Number NEU_INTERSTIM_INS
Device Problem Low Battery (2584)
Patient Problems Hypoglycemia (1912); Therapeutic Response, Decreased (2271)
Event Date 10/02/2017
Event Type  Injury  
Manufacturer Narrative
Date of event.Please note that this date is based off of the date that the article was accepted for publication as the event dates were not provided in the published literature.The main component of one of the systems involved in the reported events; other applicable components are: product id: neu_interstim_ins, lot# unknown, product type: implantable neurostimulator.The main component of the system.Other relevant device(s) are: product id: neu_interstim_ins, serial/lot #: unknown.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Laine, m., siren, j., koskenpato, j., punkkinen, j., rantanen, t., typpo, i., kokkola, a., sallinen, v.Outcomes of high-frequency gastric electric stimulation for the treatment of severe, medically refractory gastroparesis in (b)(6).Scand j surg.2017.Doi: 10.1177/1457496917748222 summary: severe, medically uncontrollable gastroparesis is a rare entity, which can be treated using a high-frequency gastric electric stimulator implanted surgically.Previous follow-ups have proven positive outcomes with gastric electric stimulator in patients with gastroparesis.The aim of this study was to evaluate the efficacy and safety of gastric electric stimulator in patients, in whom gastroparesis could not be controlled by conservative means in our country.This is a retrospective multi-center cohort comprising all patients who had been implanted gastric electric stimulator for severe, medically refractory gastroparesis during 2007¿2015 in (b)(6).Fourteen patients underwent implantation of gastric electrical stimulator without any postoperative complications.Laparoscopic approach was used in 13 patients (93%).Prior implantation, all patients needed frequent hospitalization for parenteral feeding, 13 had severe nausea, 11 had severe vomiting, 10 had notable weight loss, and 6 had frequent abdominal pain.After operation, none of the patients required parenteral feeding, 11 patients (79%) gained median of 5.1 kg in weight (p¿<(><<)> 0.01), and symptoms were relieved markedly in 8 and partially in 3 patients (79%).Of partial responders, two continued to experience occasional vomiting and one mild nausea.Five patients needed medication for gastroparesis after the operation.One patient did not get any relief of symptoms, but gained 6 kg in weight.No major late complications occurred.Gastric electrical stimulator seems to improve the nutritional status and give clear relief of the symptoms of severe, medically uncontrollable gastroparesis.Given the low number of operations, gastric electrical stimulator seems to be underused in finland.Reported events: interestingly, symptoms slowly recurred during control visits in four patients.It was found out that their ges battery was exhausted.These patients underwent battery-change reoperation.For one patient, this was done twice.Battery-change restored the functionality of the stimulator and relieved the symptoms in all four patients.No surgical complications were related to reoperations.One patient with diabetic gastroparesis continued to have hypoglycemic episodes needing hospital treatment.No specific device information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEU_INTERSTIM_INS
Type of Device
INTESTINAL STIMULATOR
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7339336
MDR Text Key102439174
Report Number3007566237-2018-00780
Device Sequence Number1
Product Code LNQ
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
H990014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other
Type of Report Initial
Report Date 03/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNEU_INTERSTIM_INS
Device Catalogue NumberNEU_INTERSTIM_INS
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/20/2018
Initial Date FDA Received03/14/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-